
Savara Secures Up to $200M in Non-Dilutive Debt Financing from Hercules Capital
Savara Inc. Secures $200 Million Loan from Hercules Capital In a recent business development, Savara Inc., a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, announced the signing of a loan and security agreement with Hercules Capital, Inc. The loan agreement enables Savara to access up to $200 million in additional capital. Strengthening Savara’s Balance…